Analytical Performances of the COVISTIX (TM) Antigen Rapid Test for SARS-CoV-2 Detection in an Unselected Population (All-Comers)


Por: Garcia-Cardenas, Francisco, Peñaloza F., Bertin-Montoya, Jennifer, Valdez-Vazquez, Rafael, Franco, Alba, Cortes, Ricardo, Frias-Jimenez, Emmanuel, Cedro-Tanda, Alberto, Mendoza-Vargas, Alfredo, Reyes-Grajeda J.P., Hidalgo-Miranda, Alfredo, Herrera, Luis A.

Publicada: 1 jun 2022
Resumen:
The performance and validity of the COVISTIX (TM) rapid antigen test for the detection of SARS-CoV-2 were evaluated in an unselected population. Additionally, we assessed the influence of the Omicron SARS-CoV-2 variant in the performance of this antigen rapid test. Swab samples were collected at two point-of-care facilities in Mexico City from individuals that were probable COVID-19 cases, as they were either symptomatic or asymptomatic persons at risk of infection due to close contact with SARS-CoV-2 positive cases. Detection of the Omicron SARS-CoV-2 variant was performed in 91 positive cases by Illumina sequencing. Specificity and sensitivity of the COVISTIX (TM) rapid antigen test was 96% (CI 95% 94-98) and 81% (CI 95% 76-85), respectively. The accuracy parameters were not affected in samples collected after 7 days of symptom onset, and it was possible to detect almost 65% of samples with a Ct-value between 30 and 34. The COVISTIX (TM) antigen rapid test is highly sensitive (93%; CI 95% 88-98) and specific (98%; CI 95% 97-99) for detecting Omicron SARS-CoV-2 variant carriers. The COVISTIX (TM) rapid antigen test is adequate for examining asymptomatic and symptomatic individuals, including those who have passed the peak of viral shedding, as well as carriers of the highly prevalent Omicron SARS-CoV-2 variant.

Filiaciones:
Garcia-Cardenas, Francisco:
 Instituto Nacional de Medicina Genómica, Periférico Sur 4809, Arenal Tepepan, Tlalpan, Mexico City, 14610, Mexico

 Inst Nacl Med Genom, Periferico Sur 4809, Mexico City 14610, DF, Mexico

Peñaloza F.:
 Instituto Nacional de Medicina Genómica, Periférico Sur 4809, Arenal Tepepan, Tlalpan, Mexico City, 14610, Mexico

Bertin-Montoya, Jennifer:
 Centro Citibanamex COVID, Mexico City, 11200, Mexico

 Ctr Citibanamex COVID, Mexico City 11200, DF, Mexico

Valdez-Vazquez, Rafael:
 Centro Citibanamex COVID, Mexico City, 11200, Mexico

 Ctr Citibanamex COVID, Mexico City 11200, DF, Mexico

Franco, Alba:
 Instituto Nacional de Medicina Genómica, Periférico Sur 4809, Arenal Tepepan, Tlalpan, Mexico City, 14610, Mexico

 Inst Nacl Med Genom, Periferico Sur 4809, Mexico City 14610, DF, Mexico

Cortes, Ricardo:
 Instituto Nacional de Medicina Genómica, Periférico Sur 4809, Arenal Tepepan, Tlalpan, Mexico City, 14610, Mexico

 Inst Nacl Med Genom, Periferico Sur 4809, Mexico City 14610, DF, Mexico

Frias-Jimenez, Emmanuel:
 Instituto Nacional de Medicina Genómica, Periférico Sur 4809, Arenal Tepepan, Tlalpan, Mexico City, 14610, Mexico

 Inst Nacl Med Genom, Periferico Sur 4809, Mexico City 14610, DF, Mexico

Cedro-Tanda, Alberto:
 Instituto Nacional de Medicina Genómica, Periférico Sur 4809, Arenal Tepepan, Tlalpan, Mexico City, 14610, Mexico

 Inst Nacl Med Genom, Periferico Sur 4809, Mexico City 14610, DF, Mexico

Mendoza-Vargas, Alfredo:
 Instituto Nacional de Medicina Genómica, Periférico Sur 4809, Arenal Tepepan, Tlalpan, Mexico City, 14610, Mexico

 Inst Nacl Med Genom, Periferico Sur 4809, Mexico City 14610, DF, Mexico

Reyes-Grajeda J.P.:
 Instituto Nacional de Medicina Genómica, Periférico Sur 4809, Arenal Tepepan, Tlalpan, Mexico City, 14610, Mexico

Hidalgo-Miranda, Alfredo:
 Instituto Nacional de Medicina Genómica, Periférico Sur 4809, Arenal Tepepan, Tlalpan, Mexico City, 14610, Mexico

 Inst Nacl Med Genom, Periferico Sur 4809, Mexico City 14610, DF, Mexico

Herrera, Luis A.:
 Instituto Nacional de Medicina Genómica, Periférico Sur 4809, Arenal Tepepan, Tlalpan, Mexico City, 14610, Mexico

 Unidad de Investigación Biomédica en Cáncer, Instituto Nacional de Cancerología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City, 04510, Mexico

 Inst Nacl Med Genom, Periferico Sur 4809, Mexico City 14610, DF, Mexico

 Univ Nacl Autonoma Mexico, Inst Invest Biomed, Inst Nacl Cancerol, Unidad Invest Biomed Canc, Mexico City 04510, DF, Mexico
ISSN: 20760817





Pathogens
Editorial
MDPI AG, ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND, Suiza
Tipo de documento: Article
Volumen: 11 Número: 6
Páginas:
WOS Id: 000911483600001
ID de PubMed: 35745482
imagen gold, Green Published, All Open Access, Gold, Green

MÉTRICAS